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Abstract
Cartilaginous tissue requires structural and metabolic support after trau-
matic or chronic injuries because of its limited capacity for regeneration. 
However, current techniques for cartilage regeneration are either invasive 
or ineffective for long-term repair. Developing alternative approaches to 
regenerate cartilage tissue is needed. Therefore, versatile scaffolds formed 
by biomaterials are promising tools for cartilage regeneration. Bioactive 
scaffolds further enhance the utility in a broad range of applications 
including the treatment of major cartilage defects. This chapter provides 
an overview of cartilage tissue, tissue defects, and the methods used for 
regeneration, with emphasis on peptide scaffold materials that can be used 
to supplement or replace current medical treatment options.
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Cartilage is a connective tissue that  structurally 
supports the body and assists in movement by 
creating low-friction platforms between the 
articular spaces of bone. Cartilaginous tissue 
does not contain any  vascular and nervous ele-
ments, which severely limits its capacity for 
regeneration following injury (Ateshian 2007). 
Microfracture and autograft transplantation 
techniques are the current medical standards 
for the repair of cartilage damage. However, 
these methods are not fully capable of restor-
ing the structural and functional integrity of 
cartilage tissue, necessitating the development 
of alternative procedures. The extracellular 
matrix (ECM) is responsible for the lubrica-
tion and articulation functions of cartilage. 
Therefore, ECM-mimetic intelligent and tun-
able scaffolds can serve as a temporary 
replacement for cartilage tissue while supply-
ing the environmental conditions necessary 
for its regeneration. Modified polymers and 
peptides can also be utilized for the recruit-
ment of mesenchymal stem cells to the dam-
aged area, thereby promoting the formation of 
neo-cartilage tissue. However, these scaffolds 
must be biocompatible and biodegradable in 
order to minimize immunogenic responses, 
stimulate cell proliferation and integrate 
 effectively with the surrounding tissue. In 
addition, they should have a porous structure 
to facilitate cellular migration and communi-
cation, and exhibit mechanical properties 
resembling native cartilage tissue to support 
newly formed tissues and provide the  necessary 
signals for cellular recruitment and 
differentiation.
This chapter presents the features of carti-
lage tissue, its diseases, and the methods devel-
oped for promoting its regeneration. A broad 
overview of the advantages and disadvantages 
associated with both recent and established 
treatment options are discussed to provide fur-
ther focus on the use of peptide bearing poly-
mers and self- assembled peptide gels for 
cartilage engineering.
7.2  Cartilage Tissue
7.2.1  Structure of Cartilage Tissue
Cartilage tissue has a limited capacity for 
 regeneration due to its avascular, aneural and 
alymphatic nature, which prevents the influx of 
oxygen, nutrients and biochemical signals that 
are required for effective wound repair. In addi-
tion, cartilage regeneration occurs through the 
activity of native chondrocytes and mesenchymal 
stem cells (MSCs), which have sparse popula-
tions and cannot facilitate the complete repair of 
large defects. Consequently, cartilage has a ten-
dency to accumulate partially repaired defects 
with age, which progressively impairs tissue 
function and may result in degenerative joint 
 diseases such as osteoarthritis, severely lowering 
the quality-of-life in the elderly population in 
particular.
Cartilage tissue is composed of cartilage- 
specific cells (chondrocytes) that constitute 3–5% 
of the adult articular cartilage by mass and are 
embedded in a highly dense ECM (Han et al. 
2011). MSCs are also present in cartilage tissue, 
especially in the deep part of the perichondrium, 
where they encircle the cartilage and may differ-
entiate into chondroblasts (Slomianka 2009). 
However, cartilage is mostly composed of ECM 
elements, and load-bearing, the main function of 
cartilage tissue, is provided mainly by the 
 macromolecular components of dense ECM 
(Taipaleenmaki 2010). In addition to its 
 mechanical integrity, cartilage tissue also pro-
vides joint lubrication and articulation, and the 
ECM microenvironment likewise plays crucial 
roles in these functions (Han et al. 2011). The 
cartilage ECM is composed mainly of a fibrillar 
collagen network that is supported by various 
proteoglycans (Han et al. 2011). Among the 
 collagen fibrils, type II collagen is the primary 
structural component found in cartilage 
ECM. Other cartilage- associated collagens 
include types III, VI, IX, X, XI, XII and XIV, 
which all contribute to the mature extracellular 
microenvironment (Eyre 2002). Besides collagen 
fibrils, the cartilage ECM also contains 
 proteoglycans such as aggrecan, chondroitin sul-
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fate glycosaminoglycan, keratin sulfate 
 glycosaminoglycan, hyaluronan, and glycopro-
tein lubricin (PRG4) (Lin et al. 2005). These 
 cartilage-specific proteins are responsible for 
establishing the morphology and function of the 
tissue, and their malfunction contributes to the 
secondary expansion of cartilage defects. 
Consequently, the induction of proteoglycan 
 synthesis is a promising approach for promoting 
the recovery of cartilage injuries.
7.2.2  Cartilage Diseases
Osteoarthritis is an inflammatory disease that is 
associated with the deterioration and erosion of 
articular cartilage, and occurs in response to a 
combination of genetic, metabolic and biochemi-
cal factors (Felson et al. 1997). The osteoarthritis 
(OA) is a pathological condition involving the 
interactions of cartilage, bone and synovium. 
Aging (and the associated mechanical wear in 
joints) is the main cause for osteoarthritis and 
other degenerative cartilage disorders, although 
joint problems can also manifest following trau-
matic accidents and in obese persons (Grotle 
et al. 2008). One major problem in the treatment 
of OA and similar diseases is the progressive loss 
of tissue integrity resulting from day-to-day 
activity and the bodily weight, as cartilage exhib-
its a minimal capacity of self-renewal that can 
easily be overwhelmed by such factors. 
Consequently, the pathophysiological formation 
of OA is predominantly due to the destabilization 
of the anabolic and catabolic dynamics of carti-
lage, which results in the progressive destruction 
of the tissue (Moreland 2003) This process is 
regulated by cytokines, growth hormones and 
enzymes (aggrecanases, matrix metalloprotein-
ases, etc.) synthesized by chondrocytes and syno-
vial cells. During OA formation, collagen 
degradation increases, proteoglycan content 
decreases, types of macromolecules change, and 
water content increases (Fig. 7.1, Heinegård and 
Saxne 2011; Belcher et al. 1997; Brandt et al. 
2000; Moreland 2003). In addition, the amount 
and molecular size of hyaluronic acid in the 
synovial fluid are also reduced (Belcher et al. 
1997). Such progressive degeneration is a very 
invasive process, and early intervention is key for 
its management: radiological osteoarthritic find-
ings may develop in less than 10 years when the 
patients are not treated during the early period of 
injury (Prakash and Learmonth 2002). Even 
small (~10 mm) defects can result in the  reduction 
of 50% or more of cartilage tissue in the joint, 
while larger (>10 mm) defects are known to 
 provide an additional burden of 64% to the sur-
rounding cartilage, as observed in a 14-year 
 follow up study (Kock et al. 2008). Due to their 
severe and long-lasting effects, the treatment of 
cartilage diseases has been a subject of intensive 
study, although effective methods for promoting 
long-term tissue repair are yet to be discovered. 
Therefore, there is an urgent medical need for 
alternative treatment options and new multifunc-
tional biomaterials that are able to respond to 
 cartilage damage in a short period of time.
7.2.3  Clinical Treatment Strategies 
for Cartilage Regeneration
The microfracture technique is one of the most 
common treatment methods against cartilage 
damage. This method is based on the  introduction 
of mesenchymal stem cells from lower bone into 
cartilage defects following the induction of local 
bleeding with the help of small needles. However, 
in the absence of a supportive artificial matrix, 
stem cells recruited in this manner generate 
fibrous tissue formations that are structurally and 
biomechanically dissimilar to the natural 
 architecture of cartilage. In addition, successful 
treatment requires an accurate assessment of the 
extent of cartilage damage. In the clinic, 
arthroscopic debridement and lavage are per-
formed for patients with less than 2 cm2 of 
 cartilage damage, as this method involves the 
cleaning of the site of injury and minimizes local 
pain resulting from frictional forces acting on 
 damaged cartilage. This treatment method is 
 generally more suitable for elderly patients, who 
are less mobile and do not run the risk of causing 
further damage to the site of injury through active 
 movement (Gaissmaier et al. 2008). In contrast, 
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the microfracture method is preferred for defect 
sizes in the range of 2–3 cm2. This method is 
especially suitable for stimulating the migration 
of MSCs from bone marrow to cartilage, allow-
ing new cartilage formation in full-thickness 
 cartilage injuries (Kreuz et al. 2006). However, 
effective cartilage repair in this method is contin-
gent upon the minimization of movement and 
mechanical loading at the affected site. In 
 addition, mid- and long-term follow-up studies 
have shown that hyaline cartilage formation is 
limited and the newly formed tissue is dominated 
by fibrous cartilage following microfracture 
 surgery: Although a hyaline-like cartilaginous 
matrix is initially formed at the site of injury, this 
material eventually acquires a fibrous character 
and deteriorates due to its inadequate mechanical 
and viscoelastic properties. Consequently, the 
joint gradually loses its functionality following 
surgery and must be replaced by prosthetics (Li 
et al. 2009). In this context, cell and tissue 
implantation studies are generally applied as a 
secondary treatment method in patients with car-
tilage damage greater than 2 cm2. This treatment 
method is performed by transplanting chondral 
and osteochondral autografts in patients who do 
not respond well to lavage and microfracture 
treatments. In larger injuries, damaged cartilage 
tissue from non-load bearing joint regions may 
also be implanted. An important advantage of 
this method is the use of healthy, functional 
 cartilage tissue, which can be obtained through 
arthroscopy. However, the implantation further 
damages the healthy tissue that surrounds the 
defect site, preventing the uniform integration of 
the autograft (Gillogly et al. 1998). Considering 
the disadvantages of these clinically applied 
treatment modalities, alternative treatment meth-
ods are needed for the effective recovery of 
 cartilage injuries. Tissue engineering is a new 
Fig. 7.1 (a) Representation of healthy joint of articular 
cartilage. Pericellular, territorial and interterritorial matri-
ces form articular cartilage and each of them place at par-
ticular distance from the chondrocytes. Inset image 
indicates the immunohistochemistry of cartilage oligo-
meric matrix protein (COMP). While the territorial and 
pericellular matrices (dashed arrow) did not stained, the 
interterritorial matrix stains for COMP (solid arrow). (b) 
Representation of osteoarthritic joint. Although disease is 
at early stages, degeneration of cartilage partially, altera-
tion in the underlying bone and cloning and reproduction 
of cells were observed in joints. No immunohistochemis-
try staining for COMP at interritorial matrix (solid arrow) 
and storage of newly synthesized COMP at pericellular 
matrix of the cartilage (dashed arrow) demonstrate the 
cloning of cells is not distinct yet (Reprinted from 
Heinegård and Saxne 2011)
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and promising approach to enhance cartilage 
 tissue regeneration, and a variety of biomaterials 
and cell culture methods have been developed to 
eliminate the deficiencies associated with 
 conventional methods of cartilage repair.
7.3  Biomaterials for Cartilage 
Regeneration
Since cartilage has a limited capacity for regen-
eration, cells require additional biochemical and 
mechanical signals to effectively facilitate defect 
closure. Biomaterial scaffolds are next- generation 
tools for tissue engineering studies, and provide a 
combination of these signals in a 3D microenvi-
ronment to promote cellular attachment and 
 proliferation. In addition, the highly porous 
structure of biomaterial scaffolds allows them to 
mediate the cell-cell interactions and signaling 
pathways that assists in cartilage repair (Ge et al. 
2012). Biocompatibility and biodegradability are 
indispensable characteristics of all biomaterials 
designed for tissue applications, while flexibility, 
elasticity and customizable mechanical strength 
are required to emulate the natural environment 
of cartilage in particular (Pearle et al. 2005).
7.3.1  Natural and Synthetic 
Scaffolds
A broad range of both natural and synthetic bio-
materials have been used to support cell adhe-
sion, viability, proliferation, and differentiation 
in cartilage tissue engineering studies. Natural 
scaffolds can be extracted from live organisms 
and include materials such as collagens, GAGs 
and decellularized cartilage of animal origin. 
Foremost among these materials is hyaluronic 
acid, which is a carbohydrate-based, non-sulfated 
glycosaminoglycan that is found abundantly in 
cartilage tissue and promotes chondrocyte prolif-
eration as well as chondrogenesis in MSCs. 
Many applications of this material exist in the 
literature: For example, a hyaluronic acid 
 derivative biopolymer (Hyaff®-11) was seeded 
with autologous chondrocytes and shown to 
enhance the quality of newly formed cartilage tis-
sue following its direct injection into full-thick-
ness cartilage defects (Grigolo et al. 2001). 
Collagens (mostly type II) are also common in 
the natural cartilage ECM, and see frequent use 
in tissue engineering applications due to their 
lack of toxicity, ability to integrate rapidly into 
surrounding tissues, and role as a flexible plat-
form for the attachment, proliferation and differ-
entiation of cells. In addition, chondrocytes were 
shown to maintain their morphology and exhibit 
enhanced GAG production when seeded on por-
cine cartilage- derived type II collagen (Nehrer 
et al. 1997). Alginate and agarose are polysac-
charide biomaterials that originate from seaweed 
and show good biocompatibility and cytocom-
patibility; however, their poor degradation kinet-
ics and limited potential for functional 
modification limits their clinical use (Murphy 
and Sambanis 2001). Fibrin is another natural 
scaffold that is derived from blood and has been 
shown to modulate cartilage formation in vivo by 
facilitating the adhesion of chondrocytes 
(Fussenegger et al. 2003). Nevertheless, fibrin is 
mechanically inadequate for cartilage tissue 
engineering, and its degradation rate is unstable. 
Thus, it cannot provide a suitable environment as 
a scaffold for cartilage repair.
Batch-to-batch variations and donor 
 requirements of natural scaffolds have led to the 
fabrication of synthetic scaffolds with controlla-
ble porosity, biodegradability and mechanical 
functions. Polymeric materials are typically pre-
ferred for the creation of synthetic materials due 
to their ease of fabrication and chemical modifi-
cation. Poly-glycolic acid (PGA) is a popular 
material for cartilage autograft studies, and chon-
drocytes were shown to actively replace the poly-
mer matrix with native ECM components when 
seeded onto PGA surfaces (Grande et al. 1997). 
In addition, PGA can form a copolymer with 
poly-lactic acid (PLA), and this material (poly- 
lactic- co-glycolic acid, PLGA) can be engineered 
to exhibit strong biocompatibility and precise 
control over degradation rates by adjusting the 
mixing ratios of PGA and PLA. PLGA offers a 
flexible environment for cartilage regeneration 
and was shown to mediate the differentiation of 
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adipose-derived adult stem cells into heterogenic 
cartilage cell populations, which can be utilized 
for further cartilage engineering applications 
(Mehlhorn et al. 2009).
7.3.2  Composite Scaffolds
Hybrid scaffolds offer novel options for cartilage 
regeneration by combining the features of indi-
vidual scaffold elements. For example, chondroi-
tin sulfate (CS) is one of the essential components 
of cartilage ECM, and the addition of CS to a 
porous network will enhance the proliferation 
and differentiation of chondrocytes and provide a 
degree of bioadhesiveness. Likewise, methyacry-
late and aldehyde groups can be integrated into 
scaffolds in order to establish additional bonds 
between biomaterials and tissue proteins. Poly 
(ɛ-caprolactone) (PCL) is a common material for 
such functionalization efforts, as it supports cell 
attachment, proliferation and ECM production, 
allowing it to mediate the repair of defect sites 
and formation of full-thickness cartilage, and the 
Food and Drug Administration (FDA) approves 
the clinical use of PCL (Garcia-Giralt et al. 
2008). Due to the hydrophobic character of PCL, 
the cellular recognition and degradation of this 
polyester is relatively difficult compared to other 
biomaterials. The integration of polyethylene 
glycol (as methoxyl poly (ethylene glycol) 
methyl ether) to PCL enhances the bioactivity of 
the hydrogel by modulating its hydrophobicity 
and biodegradability. Graphene oxide (GO) can 
also be added to these scaffolds to create a more 
advanced biomaterial with high mechanical 
strength, conductivity and overall contact area for 
biological interactions (Lee et al. 2011). The 
resulting material is a highly porous, elastic, 
swellable scaffold that has the capacity to convey 
electricity and is not degraded easily in biological 
environments, allowing it to establish a suitable 
long-term environment for cartilage regenera-
tion. (Liao et al. 2015)
Synthetic scaffolds can be further modified 
through the integration and controlled release of 
bioactive factors that play important roles in the 
regeneration process, such as growth factors and 
hormones. Platelet rich plasma (PRP) contains an 
elevated level of growth factors, yet its clinical 
use is limited due to its low mechanical strength 
and the burst release of its constituent growth fac-
tors (Fortier et al. 2011). However, PRP can be 
mixed with PCL and integrated into a gelatin 
membrane through the emulsion electrospinning 
method, producing a composite material that 
shows high bioactivity and can sustainably 
release growth factors to stimulate cellular attach-
ment in vitro and support intrinsic cartilage 
regeneration in vivo (Liu et al. 2015).
In addition to soluble factors, cellular recruit-
ment and integration are also crucial for the suc-
cess of biomaterial scaffolds. Due to the limited 
availability of chondrocytes in cartilage tissue, 
many studies have focused on the use of other 
cell types to mediate cartilage maintenance and 
repair following injury. Neonatal chondrocytes 
(NChons) are the preferred allogeneic cell type 
for the regeneration of cartilage, but the limited 
amount of donors prevents their widespread use 
in clinical settings. Nevertheless, successful cul-
turing environments of NChons were developed 
using biomaterial scaffolds, such as a 3D hydro-
gel composed of poly (ethylene glycol diacry-
late) and chondroitin sulfate methacrylate. 
Despite this, however, tissue engineering applica-
tions typically rely on MSCs, which are available 
in abundance, proliferate readily under culture 
conditions, and can differentiate into chondro-
cytes. The maintenance of these cells in bioactive 
scaffolds is an effective means of inducing their 
differentiation into specific cell lines, and both 
natural and synthetic scaffolds have been used to 
support the adhesion, viability, proliferation and 
differentiation of MSCs. These scaffolds should 
have a specific set of features to succeed in this 
role: They must be biocompatible, exhibit mini-
mal immunogenicity and toxicity, possess a 
microporous nature to ensure oxygen and nutri-
ent transport, allow cells to remodel the scaffold 
matrix through biodegradation, and alter the stem 
cell differentiation process to result in a single, 
specific cell type (Tombuloglu et al. Tombuloglu 
et al. 2012). Consequently, mimicking the natural 
ECM of cartilage tissue is a complex process that 
requires the incorporation of various biomaterial 
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components. In addition, MSCs can be derived 
from multiple sources and exhibit different phe-
notypes depending on their source. Bone-marrow 
stem cells (BMSCs) and adipose derived stem 
cells (ADSCs) are commonly used for cartilage 
repair, as they are abundant, easy to isolate and 
naturally inclined towards osteo-chondrogenic 
differentiation. Co-culture of multiple cell types 
is also possible, and large neocartilage nodules 
have been generated by increasing ADSC popu-
lations synergistically with NChons, suggesting 
that the spatial distribution of cells in 3D scaf-
folds and paracrine signaling between stem cells 
and chondrocytes are critical parameters for the 
management of cartilage tissue formation (Lai 
et al. 2013).
7.3.3  Peptide-Based Cartilage 
Engineering Scaffolds
7.3.3.1  Peptide-Edited Hydrogel 
Systems for Cartilage 
Regeneration
More effective scaffold materials can be devel-
oped through the incorporation of bioactive 
epitope- bearing peptide sequences into hydro-
gels, producing a multifunctional system that 
contains both the structural architecture and bio-
logical signals present in natural scaffolds. 
Collagen II, for example, is an abundantly found 
protein in the ECM of cartilage tissue, and the 
Streptococcal collagen-like II protein was modi-
fied with an HA-binding peptide 
(CGGGRYPISRPRKR) or CS binding peptide 
(CGGGYKTNFRRYYRF) (Chow et al. 2014) 
and an MMP7-sensitive crosslinker peptide 
(CGGGPLELRAGGGC) (Bahney et al. 2011) to 
create a versatile hydrogel providing a biode-
gradable and bioactive ECM-mimetic microenvi-
ronment. Chondrogenesis was significantly 
enhanced in human MSCs encapsulated in hydro-
gels containing the HA-binding peptide, while 
the CS-binding peptide-containing hydrogel 
increased MMP7 gene expression and ECM 
remodeling activity. As such, this multi- 
functional hydrogel was able to utilize the com-
bined effect of various peptide moieties to 
stimulate chondrogenic differentiation, and could 
be used as a minimally invasive method for the 
repair of cartilage defects (Parmar et al. 2015).
Integrated systems can compensate the defi-
ciencies of their individual components to form 
mechanically durable and bioactive epitope- 
bearing scaffolds. Demineralized bone matrix is 
flexible and strong, and presents a three- 
dimensional collagen scaffold. In addition, it is 
biocompatible, non-immunogenic and, due to its 
incorporation of various growth factors and cyto-
kines, able to stimulate osteochondrogenic differ-
entiation in vitro (Li et al. 2006) and in vivo (Gao 
et al. 2004). Together with chitosan, demineral-
ized bone forms a mechanically stronger biphasic 
hydrogel. In addition, chitosan facilitates cell 
retention and promotes the integration of newly 
formed cartilage tissue to the defect site due to its 
sol-gel transition property. This hybrid system 
can be further modified by an MSC-affine pep-
tide sequence (EPLQLKM), which increases the 
migration of MSCs to damaged cartilage tissue 
and allows the biphasic biomaterial to signifi-
cantly enhance the repair of cartilage defects 
(Fig. 7.2) (Huang et al. 2014; Meng et al. 2015).
Articular cartilage tissue is composed of super-
ficial, transitional and deep zones. Every zone 
contains different types of chondrocytes that 
secrete various amount of proteoglycans and type 
II collagen (Bhosale and Richardson 2008). 
Mimicking the layered native structure of articu-
lar cartilage may enhance the regeneration of this 
tissue, and both natural and synthetic biomaterial 
combinations can be used to form multi-layered 
functional scaffolds for this purpose. For exam-
ple, it has been shown that a polyethylene glycol 
(PEG) based hydrogel, when combined with 
chondroitin sulfate (CS), matrix metalloprotein-
ase sensitive peptide (MMP-pep) and hyaluronic 
acid scaffolds, can stimulate the formation of 
zone-specific chondrocytes from bone-marrow 
derived stem cells (BMSC) (Bhosale and 
Richardson 2008). The mechanical and biochemi-
cal stimuli provided by distinct scaffold regions 
led to the formation of specific zones exhibiting 
characteristic ECM compositions, and three zones 
of cartilage were created by the multi- layered 
hydrogel constructs. In particular, the 
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PEG:CS:MMP-pep combination differentiated 
stem cells into chondrocytes expressing elevated 
levels of collagen II and low levels of GAG, which 
is the feature of the superficial zone of cartilage, 
while the transitional zone was generated with the 
PEG:CS combination, and the PEG:HA scaffold 
promoted the formation of the deep zone. 
Collagen II expression decreased from the super-
ficial to the deep zone, while the expressions of 
collagen X and proteoglycans were enhanced in 
this direction, which is similar to the situation 
observed under in vivo conditions and can be 
applied in clinical settings for the repair of full-
thickness cartilage defects (Nguyen et al. 2011).
Fig. 7.2 (a) Representation of chitosan scaffold (CS), 
demineralized bone matrix (DBM) particles and chitosan 
hydrogel mixture (DBM/CS) scaffold, and combination 
of mesenchymal stem cells (MSCs) E7 affinity peptide 
and DBM particles within CS hydrogel scaffold. (b) 
Chemical structure of bone marrow-derived mesenchymal 
stem cells (BMMSCs) affinity peptide that is connected to 
DBM via sulfosuccinimidyl-4-(N-maleimidomethyl) 
cyclohexane-1-carboxylate (SMCC) cross-linker. (c) 
Visualization of (a) DBM and (b) DBM-E7 particles via 
SEM imaging and (c) rhodamine labeled DBM-E7 parti-
cles via confocal imaging. (d) Quantification of E7 pep-
tide conjugation on DBM particle scaffold (PA physical 
adsorption; *p < 0.05 vs. PA) (Copyright © 2015, Rights 
Managed by Nature Publishing Group (Meng et al. 2015))
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7.3.3.2  Self-Assembled Peptide Gels 
for Cartilage Regeneration
Tissue regeneration requires a complex set of 
biological signals that regulate the recruitment, 
adhesion, proliferation and differentiation of a 
broad range of cells. These signals are principally 
relayed through a fibrous extracellular matrix 
environment, and supramolecular materials are 
often designed to mimic this structure through 
noncovalent self-assembly mechanisms. 
Noncovalent interactions are preferred for scaf-
fold formation due to their ability to be reversed 
under relatively mild conditions, which allows 
both external stimuli and cellular activity to 
remodel the material during growth and differen-
tiation. In addition, noncovalent interactions are 
useful for the attachment of bioactive groups that 
replicate the functions of proteins, growth fac-
tors, cytokines and other biomolecules that play 
important roles during the tissue regeneration 
process. Peptide-based systems readily self- 
assemble under physiological conditions into 
biocompatible, biodegradable and bioactive 
epitope- bearing networks that mimic the ECM 
and support the proliferation, adhesion and 
migration of cells (Boekhoven and Stupp 2014). 
It was also shown in the study of Yaylaci et al. 
hyaluronic acid mimetic self-assembled peptide 
nanofiber gels enhance the chondrogenesis of 
MSCs and cartilage regeneration (Fig. 7.3) 
(Ustun Yaylaci et al. 2016). As such, self- 
assembled peptide gels have recently emerged as 
a class of next-generation biomaterials for tissue 
engineering applications.
Cell-seeded scaffolds for cartilage repair need 
to provide an appropriate environment for rapid 
cell division and cartilage-specific ECM deposi-
tion. Previously, chondrocytes encapsulated in 
alginate (Lemare et al. 1998) and agarose (Benya 
and Shaffer 1982) hydrogels were found to dedif-
ferentiate or fail to preserve their morphologies 
across extended culturing and passaging periods. 
However, when encapsulated into self-assembled 
gels formed by KLD-12 
(Ac-KLDLKLDLKLDL-Am) peptide molecules, 
chondrocytes were able to proliferate extensively 
while maintaining their phenotype and producing 
biomechanically functional ECM. The authors 
suggested that the utility of the system can be fur-
ther enhanced by encapsulating growth factors 
within the gel matrix and investigating whether the 
newly formed cartilage is able to integrate into sur-
rounding tissues (Kisiday et al. 2002). Cell fate can 
also be directed by controlling the release of solu-
ble factors. Consequently, cellular behaviors can be 
regulated through the encapsulation of growth fac-
Fig. 7.3 Self- assembled glycopeptide scaffold mimick-
ing hyaluronic acid. Commitment of mesenchymal stem 
cells to chondrogenesis was visualized by immunolocal-
ization of cartilage specific proteins such as aggrecan, col-
lagen II and Sox 9. Application of glycopeptide scaffold 
to osteochondral defected cartilage enhanced the regen-
eration of the tissue (Reprinted with permission from 
Ustun Yaylaci et al. 2016. Copyright 2016 American 
Chemical Society)
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tors or cytokines into tunable biomaterial networks. 
Transforming growth factor β1 (TGF-β1) is a criti-
cal molecule for the differentiation of  mesenchymal 
stem cells into chondrocytes (Barry et al. 2001), 
and the Ac-KLDLKLDLKLDL-Am peptide gel 
system was shown to stimulate the chondrogenic 
differentiation of bone marrow-derived stromal 
cells by facilitating the sustained release of this 
growth factor. Due to their flexible structures, these 
hydrogels could also be injected easily into non- 
uniform defect sites, making them promising can-
didates for the local delivery of cells and growth 
factors (Kopesky et al. 2014).
The sustained release of TGF-β1 was further 
regulated through the growth factor binding 
sequence HSNGLPL, which was discovered by 
phage display method and integrated into the 
structure of self-assembling TGFBPA hydrogels. 
These scaffolds were shown to exhibit a gradual 
release profile for TGF-β1, while rapid release 
was observed from control hydrogels. Human 
mesenchymal stem cells cultured on TGF-β1- 
encapsulated TGFBPA were viable and commit-
ted to the chondrogenic lineage. Further 
evaluation of the hydrogel was performed on an 
in vivo microfracture-treated chondral defect 
model, and TGF-β1 binding epitope density was 
found to strongly affect both the growth factor 
release profile and the chondrogenic regeneration 
capacity. In addition, TGFBPA was able to trig-
ger cell differentiation and type II collagen 
expression even in the absence of encapsulated 
TGF-β1, possibly by retaining endogenously 
produced TGF-β1 (Shah et al. 2010).
Bioactivity of scaffold materials can also be 
enhanced by the combination of relatively large 
polymers with small self-assembled peptides. 
For example, the mixing of hydroxyapatite with 
the palmitoyl-V3A3K3-Am peptide sequence was 
shown to result in the creation of a solid 
 membrane at the interface between the two com-
ponents, where the negatively-charged HA mol-
ecules were encapsulated by the positively- charged 
PA networks to form HA-filled sac structures. 
Viability analyses revealed that gel-filled sacs 
supported the survival of hMSCs and enhanced 
collagen type II expression in culture experi-
ments with chondrogenic media supplemented 
with TGF-β1, suggesting that the sacs supply an 
environment conducive to the chondrogenic 
 differentiation of mesenchymal stem cells 
(Capito et al. 2008).
Self-assembled peptide nanonetworks are 
generally more effective inducers of differentia-
tion than other scaffold materials due to their 
ability to incorporate bioactive sequences in their 
structure. Chondrogenesis of bone marrow stem 
cells, for example, was found to be more exten-
sive in self-assembling PA hydrogels compared 
to bulk hydrogels such as agarose. 3D encapsula-
tion of BMSCs into RAD16-I (AcN- (KLDL)3– 
CNH2 and RAD16-I ((RADA)4) promoted early 
chondrogenesis as a result of enhanced TGF-β1 
signaling compared to agarose controls. Since the 
mechanical characteristics of both systems were 
similar, morphological differences during chon-
drogenesis can be attributed to sequence-specific 
signals. While cell-to-cell contact was present in 
the RAD16-I systems, multicellular clusters were 
observed only in the KLD12 hydrogel, and the 
integration of biochemical and biomechanical 
signals into the peptide scaffolds was found to 
allow precise control over the differentiation of 
MSCs (Kopesky et al. 2010).
7.4  Conclusion
Due to the low regenerative capacity of cartilage, 
even minor tissue defects can cause severe health 
problems without early intervention. While carti-
lage repair can be induced through the external 
administration of stem cells and growth factors, 
the lack of native blood vessels in cartilage 
requires the local delivery of the requisite cells 
and biomolecules, and scaffolds are ideal 
 materials for this purpose. Invasive techniques 
such as autologous chondrocyte transplantation 
or microfractures can be used to stimulate 
 cartilage repair, but are associated with severe 
disadvantages such as fibrosis and collateral tis-
sue damage. Thus, recent advances in cartilage 
tissue engineering are encouraging from a  clinical 
point of view. The facile synthesis and structural 
modification of injectable scaffolds is promising 
for the effective regeneration of large structural 
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defects in cartilage. ECM-mimetic, porous and 
bioactive scaffolds are ideal materials for modu-
lating the signaling networks responsible for car-
tilage formation and biointegration without 
eliciting undesirable immune complications. 
Further achievements in cartilage regeneration 
are expected to improve the quality of life of the 
elderly in particular, but it must nevertheless be 
noted that clinical studies involving  peptide- based 
scaffolds are currently uncommon and that much 
work needs to be performed to suitably 
 demonstrate the safety and efficiency of this new 
class of biomaterials for cartilage regeneration.
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